Sherif A M, Ammar M A, Mostafa Y S, Gamal Eldin S A, Osman A A
Department of Ophthalmology, Faculty of Medicine, Cairo University, Cairo 12411, Egypt.
J Ophthalmol. 2015;2015:321953. doi: 10.1155/2015/321953. Epub 2015 Aug 23.
Purpose. To evaluate effectiveness of simultaneous topography-guided photorefractive keratectomy and corneal collagen cross-linking in mild and moderate keratoconus. Methods. Prospective nonrandomized interventional study including 20 eyes of 14 patients with grade 1-2 keratoconus that underwent topography-guided PRK using a Custom Ablation Transition Zone (CATz) profile with 0.02% MMC application immediately followed by standard 3 mw/cm(2) UVA collagen cross-linking. Maximum ablation depth did not exceed 58 μm. Follow-up period: 12 months. Results. Progressive statistically significant improvement of UCVA from 0.83 ± 0.37 logMAR preoperative, reaching 0.25 ± 0.26 logMAR at 12 months (P < 0.001). Preoperative BCVA (0.27 ± 0.31 logMAR) showed a progressive improvement reaching 0.08 ± 0.12 logMAR at 12 months (P = 0.02). Mean Kmax reduced from 48.9 ± 2.8 to 45.4 ± 3.1 D at 12 months (P < 0.001), mean Kmin reduced from 45.9 ± 2.8 D to 44.1 ± 3.2 D at 12 months (P < 0.003), mean keratometric asymmetry reduced from 3.01 ± 2.03 D to 1.25 ± 1.2 D at 12 months (P < 0.001). The safety index was 1.39 at 12 months and efficacy index 0.97 at 12 months. Conclusion. Combined topography-guided PRK and corneal collagen cross-linking are a safe and effective option in the management of mild and moderate keratoconus. Precis. To our knowledge, this is the first published study on the use of the CATz ablation system on the Nidek Quest excimer laser platform combined with conventional cross-linking in the management of mild keratoconus.
目的。评估同步地形引导的准分子激光角膜切削术和角膜胶原交联术治疗轻度和中度圆锥角膜的有效性。方法。前瞻性非随机干预性研究,纳入14例1 - 2级圆锥角膜患者的20只眼,采用定制消融过渡区(CATz)轮廓进行地形引导的准分子激光角膜切削术,应用0.02%丝裂霉素C后立即进行标准的3 mw/cm(2)紫外线A胶原交联术。最大消融深度不超过58 μm。随访期:12个月。结果。最佳矫正视力(UCVA)从术前的0.83 ± 0.37 logMAR有统计学意义的逐步改善,在12个月时达到0.25 ± 0.26 logMAR(P < 0.001)。术前最佳矫正视力(BCVA)(0.27 ± 0.31 logMAR)也逐步改善,在12个月时达到0.08 ± 0.12 logMAR(P = 0.02)。平均最大角膜曲率(Kmax)在12个月时从48.9 ± 2.8降至45.4 ± 3.1 D(P < 0.001),平均最小角膜曲率(Kmin)在12个月时从45.9 ± 2.8 D降至44.1 ± 3.2 D(P < 0.003),平均角膜曲率不对称性在12个月时从3.01 ± 2.03 D降至1.25 ± 1.2 D(P < 0.001)。12个月时安全指数为1.39,疗效指数为0.97。结论。联合地形引导的准分子激光角膜切削术和角膜胶原交联术是治疗轻度和中度圆锥角膜的一种安全有效的选择。确切地说,据我们所知,这是第一项关于在尼德克Quest准分子激光平台上使用CATz消融系统联合传统交联术治疗轻度圆锥角膜的发表研究。